Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

A long-lasting formulation of an antiviral drug greatly reduced people’s risk of a symptomatic flu infection in a trial, and ...

RNA-1010 demonstrated superior relative vaccine efficacy that was 26.6% (95% CI; 16.7%, 35.4%) higher than a licensed ...

Moderna said on Monday its influenza vaccine was found to be 26.6% more effective than an approved annual flu shot from GSK ...

Spanning nine influenza seasons, these studies enrolled 1862 patients, of whom 954 received the high-dose vaccine and 908 the standard-dose vaccine. Primary outcomes were immunogenicity (measured ...

The Subject Expert Committee (SEC) under the COVID-19 division of the Central Drugs Standard Control Organization (CDSCO) has ...

Thimerosal is found in only a small fraction of US vaccine doses but has long been viewed with suspicion by the ...

Vaccination is the most effective way to prevent infection and the more severe outcomes associated with influenza viruses. ... have shown strong immunogenicity against H1N1 experimentally, ...

The H5N1 avian influenza virus has infected birds and mammals around the world. As of June 2025, 70 people have been infected ...

The H5N1 avian influenza virus has infected birds and mammals around the world. As of June 2025, 70 people have been infected ...

Influenza A virus infection increases host transposable element (TE) expression. This study provides evidence that some infection-induced TEs form double-stranded RNAs that accumulate in the cytosol ...